2003

1. A multicenter phase II study of irinotecan (CPT-11) alternated with 5-fluorouracil and leucovorin as first-line treatment of patients with metastatic colorectal cancer

   Cancer Chemotherapy and Pharmacology, Vol. 52, Núm. 4, pp. 339-345